1. Application of H 2 N-Fe 3 O 4 Nanoparticles for Prostate Cancer Magnetic Resonance Imaging in an Animal Model.
- Author
-
Blasiak B, MacDonald D, Jasiński K, Cheng FY, and Tomanek B
- Subjects
- Male, Animals, Disease Models, Animal, Humans, Mice, Magnetite Nanoparticles chemistry, Cell Line, Tumor, Prostatic Neoplasms diagnostic imaging, Prostatic Neoplasms pathology, Magnetic Resonance Imaging methods, Contrast Media chemistry
- Abstract
This paper presents the efficacy of a contrast agent based on H
2 N-Fe3 O4 nanoparticles for the detection of prostate cancer in an animal model using a preclinical 9.4 T MRI system. The relaxivities r1 and r2 of the nanoparticles were 6.31 mM-1 s-1 and 8.33 mM-1 s-1 , respectively. Nanoparticles injected in a concentration of 2 mg Fe/mL decreased the tumor-relative T1 relaxation across all animals from 100 to 76 ± 26, 85 ± 27, 89 ± 20, and 97 ± 16 12 min 1 h, 2 h, and 24 h post injection, respectively. The corresponding T1 decrease in muscle tissues was 90 ± 20, 94 ± 23, 99 ± 12, and 99 ± 14. The relative T2 changes in the tumor were 82 ± 17, 89 ± 19, 97 ± 14, and 99 ± 8 12 min, 1 h, 2 h, and 24 h post injection, respectively, while, for muscle tissues, these values were 95 ± 11, 95 ± 8, 97 ± 6, and 95 ± 10 at the corresponding time points. The differences in the relative T1 and T2 were only significant 12 min after injection ( p < 0.05), although a decrease was visible at each time point, but it was statistically insignificant ( p > 0.05). The results showed the potential application of H2 N-Fe3 O4 nanoparticles as contrast agents for enhanced prostate cancer MRI.- Published
- 2024
- Full Text
- View/download PDF